TFX vs. BAX, HOLX, MASI, GMED, ITGR, ATEC, ATRC, IART, OFIX, and SRDX
Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), ORTHOFIX MEDICAL (OFIX), and Surmodics (SRDX). These companies are all part of the "health care equipment" industry.
Teleflex vs. Its Competitors
Teleflex (NYSE:TFX) and Baxter International (NYSE:BAX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.
Teleflex has a net margin of 4.96% compared to Baxter International's net margin of -4.71%. Baxter International's return on equity of 17.24% beat Teleflex's return on equity.
Teleflex has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
Teleflex has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.
Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.2%. Teleflex pays out 42.9% of its earnings in the form of a dividend. Baxter International pays out -61.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.
Teleflex currently has a consensus price target of $164.63, suggesting a potential upside of 37.30%. Baxter International has a consensus price target of $36.14, suggesting a potential upside of 16.29%. Given Teleflex's higher possible upside, analysts clearly believe Teleflex is more favorable than Baxter International.
95.6% of Teleflex shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 1.4% of Teleflex shares are held by company insiders. Comparatively, 0.2% of Baxter International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Teleflex had 4 more articles in the media than Baxter International. MarketBeat recorded 10 mentions for Teleflex and 6 mentions for Baxter International. Baxter International's average media sentiment score of 1.30 beat Teleflex's score of 0.64 indicating that Baxter International is being referred to more favorably in the news media.
Summary
Teleflex beats Baxter International on 11 of the 18 factors compared between the two stocks.
Get Teleflex News Delivered to You Automatically
Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Teleflex Competitors List
Related Companies and Tools
This page (NYSE:TFX) was last updated on 7/5/2025 by MarketBeat.com Staff